Filing Details
- Accession Number:
- 0001179110-12-015715
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-05 20:26:55
- Reporting Period:
- 2012-11-01
- Filing Date:
- 2012-11-05
- Accepted Time:
- 2012-11-05 20:26:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314870 | Kristen Metza | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-01 | 14,000 | $38.17 | 39,305 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-11-01 | 14,000 | $47.51 | 53,305 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-11-01 | 2,000 | $43.15 | 55,305 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-01 | 27,200 | $67.68 | 28,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-01 | 2,800 | $68.18 | 25,305 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2012-11-01 | 14,000 | $0.00 | 14,000 | $38.17 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2012-11-01 | 2,000 | $0.00 | 2,000 | $43.15 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2012-11-01 | 14,000 | $0.00 | 14,000 | $47.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,600 | 2021-01-20 | No | 4 | M | Direct | |
| 3,500 | 2018-01-30 | No | 4 | M | Direct | |
| 12,600 | 2020-01-28 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions are pursuant to a Rule 105b-1 trading plan established by Ms. Metza on February 22, 2011.
- The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $67.12 to $68.12. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $68.13 to $68.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
